SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from RAMP CORP (CIK 0000890784) — Sep 24, 2004

RAMP CORP (CIK 0000890784)
Date: Sept. 24, 2004 · CIK: 0000890784 · Accession: 0000910680-04-001007

AI Filing Summary & Sentiment

File numbers found in text: 333-118457

Referenced dates: September 15, 2004

Date
September 24, 2004
Author
Assistant Director
Form
CORRESP
Company
RAMP CORP (CIK 0000890784)

Letter

September 24, 2004 VIA EDGAR AND OVERNIGHT COURIER Ms. Barbara C. Jacobs Assistant Director Securities and Exchange Commission Division of Corporate Finance Mail Stop 4-6 450 Fifth Street, N.W. Washington, D.C. 20549

Re: Ramp Corporation Form S-3 filed August 20, 2004 Registration Statement No. 333-118457 -------------------------------------

Dear Ms. Jacobs:

We have reviewed your comment letter dated September 15, 2004, sent to Ramp Corporation (the "Company"). On behalf of the Company and based upon the Company's representations to us, we hereby respond to each comment set forth in your comment letter. The numbered paragraphs in this letter correspond to the consecutively numbered paragraphs in the comment letter.

Form S-3 --------

1. As discussed with the Staff, the letter of intent entered into on April 22, 2004 to acquire substantially all of the electronic medical record software business operated by Berdy Medical Systems, Inc. ("Berdy") is subject to the satisfaction of customary closing conditions, including the negotiation and execution of a definitive purchase agreement. To date, no definitive purchase agreement has been executed by the parties and there is no assurance that such

<PAGE>

Jenkens & Gilchrist Parker Chapin LLP

Ms. Barbara C. Jacobs Assistant Director Securities and Exchange Commission September 24, 2004 Page 2

transaction will be consummated. We have revised the disclosure under the "Recent Developments" section on page 6 of the prospectus (which forms a part of the Amendment No. 1 to the Registration Statement on Form S-3, no. 333-118457 (the "Registration Statement")) to clearly indicate that the purchase agreement has not been and may not be executed and that no assurance can be given that a definitive purchase agreement will be entered into on terms satisfactory to the Company, or that such transaction will be consummated. As a result, under Rule 3-05(a)(1)(i) of Regulation S-X, the closing of the transaction is not "probable" and financial statements or pro forma financial information are not required to be filed with the Commission.

For the Staff's information, although the closing of the transaction is not "probable", for purposes of potential disclosure requirements on Form 8-K, the Company has performed an analysis on its financial statements in comparison to the financial statements of Berdy to determine if Berdy meets any of the "significant subsidiary" tests under Rule 1-02(w) of Regulation S-X. As a result of the Company's analysis, under Rule 3-05(b)(2)(i), no financial statements or pro forma financial information of Berdy would be required to be filed if the acquisition is consummated.

The amendment to the Registration Statement was previously filed with the Commission on September 24, 2004.

Legal Matters, page 27 ----------------------

2. As requested by the Staff and in accordance with Item 509 of Regulation S-K, the Company has revised the disclosure regarding the issuance of 4,000,000 shares of common stock of the Company to Martin Eric Weisberg, Esq., for the benefit of Jenkens & Gilchrist Parker Chapin LLP, for services provided to the Company, and included such revised disclosure on page 18 of the "Description of the Transactions" section of the prospectus and on page 29 under a revised section heading of the prospectus entitled "Legal Matters/Interests of Counsel".

Conclusion ----------

The Company believes that the amended Registration Statement, together with the Company's statements set forth in this letter, satisfy all of the comments set forth in your letter. As discussed with the Staff, the Company has revised the disclosure in the prospectus forming a part of the Registration Statement to specifically incorporate the Company's Current Reports on Form 8-K filed with the Commission on September 13, 2004 and September 17, 2004, respectively, and has revised the disclosure in the prospectus accordingly.

As discussed with the Staff, request is hereby made for acceleration of the effectiveness of the above-referenced Registration Statement under the Securities Act of 1933, as amended, of the Company to Monday, September 27, 2004 at 5:00 p.m., or as soon thereafter as practicable.

<PAGE>

Jenkens & Gilchrist Parker Chapin LLP

Ms. Barbara C. Jacobs Assistant Director Securities and Exchange Commission September 24, 2004 Page 3

In connection with the Company's request for acceleration of the Registration Statement, the Company hereby acknowledges that:

o should the Commission or the Staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the filing;

o the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and

o the Company may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Please feel free to call me at (212) 704-6050 if you have any questions or if you require further information.

Very truly yours,
/s/ Martin Eric Weisberg
Martin Eric Weisberg

Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
                      Jenkens & Gilchrist Parker Chapin LLP

                                                              AUSTIN, TEXAS
                             THE CHRYSLER BUILDING           (512) 499-3800
                             405 LEXINGTON AVENUE           CHICAGO, ILLINOIS
                           NEW YORK, NEW YORK 10174          (312) 425-3900
                                                              DALLAS, TEXAS
Martin Eric Weisberg            (212) 704-6000               (214) 855-4500
 (212) 704-704-6050         FACSIMILE (212) 704-6288         HOUSTON, TEXAS
mweisberg@jenkens.com                                        (713) 951-3300
                               www.jenkens.com           LOS ANGELES, CALIFORNIA
                                                             (310) 820-8800
                                                          PASADENA, CALIFORNIA
                                                            (626) 578-7400
                                                           SAN ANTONIO, TEXAS
                                                            (210) 246-5000
                                                            WASHINGTON, D.C.
                                                             (202) 326-1500

                               September 24, 2004

VIA EDGAR AND OVERNIGHT COURIER

Ms. Barbara C. Jacobs
Assistant Director
Securities and Exchange Commission
Division of Corporate Finance
Mail Stop 4-6
450 Fifth Street, N.W.
Washington, D.C. 20549

                  Re:      Ramp Corporation
                           Form S-3 filed August 20, 2004
                           Registration Statement No. 333-118457
                           -------------------------------------

Dear Ms. Jacobs:

         We have reviewed your comment letter dated  September 15, 2004, sent to
Ramp Corporation  (the  "Company").  On behalf of the Company and based upon the
Company's  representations to us, we hereby respond to each comment set forth in
your comment letter.  The numbered  paragraphs in this letter  correspond to the
consecutively numbered paragraphs in the comment letter.

Form S-3
--------

         1. As discussed  with the Staff,  the letter of intent  entered into on
April 22, 2004 to acquire  substantially  all of the  electronic  medical record
software business operated by Berdy Medical Systems,  Inc.  ("Berdy") is subject
to the satisfaction of customary closing  conditions,  including the negotiation
and  execution  of a  definitive  purchase  agreement.  To date,  no  definitive
purchase  agreement  has been  executed by the parties and there is no assurance
that such

<PAGE>

                     Jenkens & Gilchrist Parker Chapin LLP

Ms. Barbara C. Jacobs
Assistant Director
Securities and Exchange Commission
September 24, 2004
Page 2

transaction  will be  consummated.  We have  revised  the  disclosure  under the
"Recent Developments" section on page 6 of the prospectus (which forms a part of
the Amendment No. 1 to the  Registration  Statement on Form S-3, no.  333-118457
(the "Registration  Statement")) to clearly indicate that the purchase agreement
has not been and may not be executed and that no  assurance  can be given that a
definitive  purchase agreement will be entered into on terms satisfactory to the
Company, or that such transaction will be consummated.  As a result,  under Rule
3-05(a)(1)(i)  of  Regulation  S-X,  the  closing  of  the  transaction  is  not
"probable" and financial  statements or pro forma financial  information are not
required to be filed with the Commission.

For the Staff's  information,  although  the closing of the  transaction  is not
"probable",  for purposes of potential disclosure  requirements on Form 8-K, the
Company has performed an analysis on its  financial  statements in comparison to
the  financial  statements  of Berdy to  determine  if  Berdy  meets  any of the
"significant subsidiary" tests under Rule 1-02(w) of Regulation S-X. As a result
of the Company's analysis, under Rule 3-05(b)(2)(i),  no financial statements or
pro forma  financial  information  of Berdy would be required to be filed if the
acquisition is consummated.

The  amendment  to the  Registration  Statement  was  previously  filed with the
Commission on September 24, 2004.

Legal Matters, page 27
----------------------

2. As requested by the Staff and in accordance with Item 509 of Regulation S-K,
the Company has revised the disclosure regarding the issuance of 4,000,000
shares of common stock of the Company to Martin Eric Weisberg, Esq., for the
benefit of Jenkens & Gilchrist Parker Chapin LLP, for services provided to the
Company, and included such revised disclosure on page 18 of the "Description of
the Transactions" section of the prospectus and on page 29 under a revised
section heading of the prospectus entitled "Legal Matters/Interests of Counsel".

Conclusion
----------

         The Company believes that the amended Registration Statement,  together
with the  Company's  statements  set forth in this  letter,  satisfy  all of the
comments set forth in your letter.  As discussed with the Staff, the Company has
revised the  disclosure  in the  prospectus  forming a part of the  Registration
Statement to specifically  incorporate the Company's Current Reports on Form 8-K
filed  with the  Commission  on  September  13,  2004 and  September  17,  2004,
respectively, and has revised the disclosure in the prospectus accordingly.

         As discussed with the Staff, request is hereby made for acceleration of
the  effectiveness  of the  above-referenced  Registration  Statement  under the
Securities Act of 1933, as amended, of the Company to Monday, September 27, 2004
at 5:00 p.m., or as soon thereafter as practicable.

<PAGE>

                     Jenkens & Gilchrist Parker Chapin LLP

Ms. Barbara C. Jacobs
Assistant Director
Securities and Exchange Commission
September 24, 2004
Page 3

         In  connection  with the  Company's  request  for  acceleration  of the
Registration Statement, the Company hereby acknowledges that:

         o        should  the  Commission  or  the  Staff,  acting  pursuant  to
                  delegated  authority,   declare  the  Registration   Statement
                  effective,  it does not foreclose the  Commission  from taking
                  any action with respect to the filing;

         o        the action of the Commission or the Staff,  acting pursuant to
                  delegated authority,  in declaring the Registration  Statement
                  effective,   does  not  relieve  the  Company  from  its  full
                  responsibility for the adequacy and accuracy of the disclosure
                  in the Registration Statement; and

         o        the  Company  may not assert  this  action as a defense in any
                  proceeding initiated by the Commission or any person under the
                  federal securities laws of the United States.

         Please feel free to call me at (212) 704-6050 if you have any questions
or if you require further information.

                                                    Very truly yours,

                                                    /s/ Martin Eric Weisberg
                                                    Martin Eric Weisberg

cc:  Tangela Richter, Esq.
     Mr. Andrew Brown
     Mr. Hank Clark
     Mr. Jeffrey Thomson
     Stephen G. Cordaro, Esq.

</TEXT>
</DOCUMENT>